Path Traversal in Supremainc Biostar 2
CVE-2023-33365
A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.
Vulnerability class: Path Traversal (Directory Traversal)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.
EPSS exploit prediction
EPSS: 0.007 (54.0th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 54th percentile — 54.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
Weakness classification (CWE)
References
- kb.supremainc.com/knowledge/doku.php (Release Notes, Vendor Advisory)
- claroty.com/team82/disclosure-dashboard/cve-2023-33365 (Third Party Advisory)
Frequently asked questions
- What is CVE-2023-33365?
- CVE-2023-33365 is a high-severity vulnerability in Supremainc Biostar 2, classified under Path Traversal. CVSS score: 7.5/10. Published 2023-08-03.
- How severe is CVE-2023-33365?
- High severity. CVSS v3 base score is 7.5 out of 10.